|
|
Orfiril 300 retard 300mg enteric-coated sustained-release tablets
| |
| Rinkodaros teisės |
Desitin Arzneimittel GmbH, Vokietija
|
| Registracijos nr. |
94/543/6
|
| Būsena i |
neregistruotas
|
| |
| Pavadinimas |
Orfiril 300 retard
|
| Forma |
enteric-coated sustained-release tablets
|
| Vartojimas |
nenurodytas
|
| Veiklioji medžiaga |
Natrii valproas |
| Stiprumas |
300mg
|
| Išdavimo tvarka i |
receptinis
|
| |
| ATC kodas |
N03AG01
|
| |
Valproic acid
|
| Pakuotė |
Reg. Nr. |
|
Kompensavimas i |
| MK |
BK |
Paciento priemoka |
| 100% |
90% |
80% |
50% |
|
Orfiril 300 retard 300mg enteric-coated sustained-release tablets N200 |
94/543/6
|
|
|
|
|
|
|
|
|
Orfiril 300 retard 300mg enteric-coated sustained-release tablets N50 |
94/543/6
|
|
|
|
|
|
|
|
|
Orfiril 300 retard 300mg enteric-coated sustained-release tablets N100 |
94/543/6
|
|
|
|
|
|
|
|
|
2024 balandžio 27 d., šeštadienis 
